porphobilinogen has been researched along with Hepatocellular Carcinoma in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The acute hepatic porphyrias (AHP) are rare, inborn errors of heme-metabolism and include acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of 5-aminolevulinic acid dehydratase." | 5.41 | AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review. ( Balwani, M; Bonkovsky, HL; Lim, JK; Wang, B, 2023) |
| "Acute intermittent porphyria (AIP), caused by heterozygous germline mutations of the heme synthesis pathway enzyme HMBS (hydroxymethylbilane synthase), confers a high risk of hepatocellular carcinoma (HCC) development." | 4.12 | Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma. ( Amaddeo, G; Bayard, Q; Blanc, JF; Calderaro, J; Letouzé, E; Ma, X; Molina, L; Trépo, E; Zhu, J; Zucman-Rossi, J, 2022) |
| "An elderly woman was found to have hepatocellular carcinoma and, incidental to this, markedly elevated levels of porphobilinogen in urine and serum." | 3.67 | Pseudo-porphyria in a patient with hepatocellular carcinoma. ( Bossenmaier, IC; Cardinal, RA; Pierach, CA; Weimer, MK, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molina, L | 1 |
| Zhu, J | 1 |
| Trépo, E | 1 |
| Bayard, Q | 1 |
| Amaddeo, G | 1 |
| Blanc, JF | 1 |
| Calderaro, J | 1 |
| Ma, X | 1 |
| Zucman-Rossi, J | 1 |
| Letouzé, E | 1 |
| Wang, B | 1 |
| Bonkovsky, HL | 1 |
| Lim, JK | 1 |
| Balwani, M | 1 |
| Pierach, CA | 1 |
| Bossenmaier, IC | 1 |
| Cardinal, RA | 1 |
| Weimer, MK | 1 |
| Andersson, C | 1 |
| Bylesjö, I | 1 |
| Lithner, F | 1 |
| Wainstok de Calmanovici, R | 1 |
| Cochón, AC | 1 |
| Zenklusen, JC | 1 |
| Aldonatti, C | 1 |
| Cabral, JR | 1 |
| San Martín de Viale, LC | 1 |
1 review available for porphobilinogen and Hepatocellular Carcinoma
| Article | Year |
|---|---|
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Topics: Abdominal Pain; Aminolevulinic Acid; Antiemetics; Carcinoma, Hepatocellular; Creatinine; Female; Hem | 2023 |
4 other studies available for porphobilinogen and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma.
Topics: beta Catenin; Carcinoma, Hepatocellular; Female; Heme; Humans; Hydroxymethylbilane Synthase; Liver N | 2022 |
Pseudo-porphyria in a patient with hepatocellular carcinoma.
Topics: Abdominal Neoplasms; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Feces; Female; Humans; Liv | 1984 |
Effects of diabetes mellitus on patients with acute intermittent porphyria.
Topics: Age of Onset; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Female; | 1999 |
Influence of hepatic tumors caused by diethylnitrosamine on hexachlorobenzene-induced porphyria in rats.
Topics: 5-Aminolevulinate Synthetase; Aminolevulinic Acid; Animals; Carcinoma, Hepatocellular; Cytochrome P- | 1991 |